Published

Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychopharmacology
Date: 2024-08-01
Source: PubMed
DOI: 10.1007/s00213-024-06585-x
PubMed: 38687360

Authors

Sakai K Bradley ER Zamaria JA Agin-Liebes G Kelley DP Fish A Martini V Ferris MC Morton E Michalak EE O'Donovan A Woolley JD

Watch author

Derived topics and classifications

psilocybin Receptor Pharmacology Safety Toxicity Drug Interactions Qualitative Study

Citation graph

0 referenced DOIs found in stored source metadata. 4 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03 Prevalence and Correlates of Past-Year Psilocybin Use in the United States2026-04-22 Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)2026-03-26 Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.2024-08-01

Related papers

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06